ID OXLA_ERIMA Reviewed; 27 AA. AC P0C2D3; DT 23-JAN-2007, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 1. DT 16-JUN-2009, entry version 14. DE RecName: Full=L-amino-acid oxidase; DE Short=LAAO; DE Short=LAO; DE EC=1.4.3.2; DE Flags: Fragment; OS Eristocophis macmahoni (Leaf-nosed viper). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Lepidosauria; Squamata; Scleroglossa; Serpentes; Colubroidea; OC Viperidae; Viperinae; Eristocophis. OX NCBI_TaxID=8702; RN [1] RP PROTEIN SEQUENCE, FUNCTION, SUBUNIT, AND MASS SPECTROMETRY. RC TISSUE=Venom; RX PubMed=11368308; DOI=10.1006/abbi.2000.2130; RA Ali S.A., Stoeva S., Abbasi A., Alam J.M., Kayed R., Faigle M., RA Neumeister B., Voelter W.; RT "Isolation, structural, and functional characterization of an RT apoptosis-inducing L-amino acid oxidase from leaf-nosed viper RT (Eristocophis macmahoni) snake venom."; RL Arch. Biochem. Biophys. 384:216-226(2000). CC -!- FUNCTION: Catalyzes an oxidative deamination of predominantly CC hydrophobic and aromatic L-amino acids. Induces edema and platelet CC aggregation. Has a potent hemolytic activity. Has an ability to CC induce apoptosis. Unlike other snake venom L-amino acid oxidases, CC does not induce hemorrhage. May have an antibacterial activity. CC -!- CATALYTIC ACTIVITY: An L-amino acid + H(2)O + O(2) = a 2-oxo acid CC + NH(3) + H(2)O(2). CC -!- COFACTOR: FAD (By similarity). CC -!- SUBUNIT: Homodimer. CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- TISSUE SPECIFICITY: Expressed by the venom gland. CC -!- PTM: Glycosylated (By similarity). CC -!- MASS SPECTROMETRY: Mass=58734.0; Method=MALDI; Range=1-?; CC Source=PubMed:11368308; CC -!- SIMILARITY: Belongs to the flavin monoamine oxidase family. FIG1 CC subfamily. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR HOVERGEN; P0C2D3; -. DR BRENDA; 1.4.3.2; 279510. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0001716; F:L-amino-acid oxidase activity; IEA:EC. DR GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW. DR GO; GO:0007596; P:blood coagulation; IEA:UniProtKB-KW. DR GO; GO:0019835; P:cytolysis; IEA:UniProtKB-KW. DR GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW. DR GO; GO:0019836; P:hemolysis by symbiont of host erythrocytes; IEA:UniProtKB-KW. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW. PE 1: Evidence at protein level; KW Antibiotic; Antimicrobial; Apoptosis; Blood coagulation; Cytolysis; KW Direct protein sequencing; FAD; Flavoprotein; Glycoprotein; Hemolysis; KW Oxidoreductase; Secreted; Toxin. FT CHAIN 1 >27 L-amino-acid oxidase. FT /FTId=PRO_0000273568. FT NON_TER 27 27 SQ SEQUENCE 27 AA; 3097 MW; 18DBFD66E0655CE7 CRC64; ADDKNPLEEA FREADYEVFL EIAKNGL //